Arbutus Biopharma
ABUS
#6232
Rank
C$1.18 B
Marketcap
C$6.18
Share price
-1.33%
Change (1 day)
18.67%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): C-$0.46

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is C-$0.46. In 2024 the company made an earnings per share (EPS) of C-$0.53 an increase over its 2023 EPS that were of C-$0.61.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.46-12.78%
2024C-$0.53-13.64%
2023C-$0.61-4.35%
2022C-$0.64-44.58%
2021C-$1.15-17%
2020C-$1.39-65.4%
2019C-$4.00138.84%
2018C-$1.68-22.44%
2017C-$2.16-78.45%
2016C-$10.03424.64%
2015C-$1.91-20.19%
2014C-$2.4087.96%
2013C-$1.27-142.59%
2012C$2.99-342.7%
2011C-$1.23-25.82%
2010C-$1.6647.8%
2009C-$1.12-43.55%
2008C-$1.99158.91%
2007C-$0.77-111.88%
2006C$6.48-552.53%
2005C-$1.43-71.77%
2004C-$5.07-14.48%
2003C-$5.93-8.95%
2002C-$6.5170.07%
2001C-$3.8348.01%
2000C-$2.59-38.54%
1999C-$4.21-24.6%
1998C-$5.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
NRC Health
NRC
C$0.97-312.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
C-$0.08312-81.82% Bahamas